Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score

Alberto Cordero1,2, Belén Cid-Alvarez2,3, Eduardo Alegría4

  • 1Cardiology Department, Hospital Universitario de San Juan, Alicante, Spain.

Insights

Manual thrombectomy (MT) can improve outcomes in primary percutaneous coronary intervention (P-PCI) for select patients. The DDTA score effectively identifies patients who benefit most from MT, reducing complications and mortality.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Routine manual thrombectomy (MT) is not recommended in primary percutaneous coronary intervention (P-PCI).
  • Despite recommendations, MT is frequently performed in P-PCI procedures.
  • The DDTA score was developed to identify patients who could benefit most from MT.

Purpose of the Study:

  • To validate the DDTA score for patient selection in MT during P-PCI.
  • To assess the association between the DDTA score and clinical outcomes.
  • To evaluate the impact of MT on specific endpoints in relation to the DDTA score.

Main Methods:

  • Multicenter observational study of consecutive patients undergoing P-PCI.
  • Validation of the DDTA score against a design cohort.
  • Analysis of primary endpoint (TIMI 3 after MT) and secondary endpoints (final TIMI 3, no-reflow, mortality, MACE).
  • Assessment of in-hospital prognosis using the Zwolle risk score.

Main Results:

  • The validation cohort (340 patients) showed similar characteristics to the design cohort (618 patients) but with less MT use.
  • Higher DDTA scores were linearly associated with improved outcomes.
  • MT was associated with TIMI 3 flow (OR: 4.11) and final TIMI 3 (OR: 2.44) in patients with a DDTA score ≥ 4.
  • A DDTA score ≥ 4 was independently linked to reduced no-reflow, in-hospital MACE, and mortality.

Conclusions:

  • MT is associated with a higher rate of final TIMI 3 flow in patients with a DDTA score ≥ 4.
  • Patients with a DDTA score ≥ 4 experienced lower rates of no-reflow and in-hospital complications.
  • The DDTA score is a valuable tool for selecting patients who benefit from MT in P-PCI.
Abstract